Sleep Disorders News

New estimates indicate that nearly 1 billion adults around the world have mild to severe obstructive sleep apnea, about half of whom have moderate to severe disease, according to a study published in The Lancet Respiratory Medicine.

The positive sleep changes that older residents of Finland experienced after retirement was likely not caused by the removal of difficult work situations, according to findings recently published in Sleep.

Researchers found that 14% of 125 suicidal adults with major depressive disorder, who were not suspected to have obstructive sleep apnea, actually did meet diagnostic criteria for the condition.

Positive airway pressure as a treatment for obstructive sleep apnea showed greater improvement in blood pressure than upper airway stimulation, but sleepiness symptoms were improved most using upper airway stimulation, according to a study published in CHEST.

Some children may experience complete resolution of obstructive sleep apnea as they transition to adulthood, but persistent disease is more likely in those with certain characteristics, according to data published in CHEST.

Continuous positive airway pressure treatment reduced depressive symptoms in patients with co-existing obstructive sleep apnea and cardiovascular disease, study findings showed.

Myofunctional therapy — previously defined in Sleep as isotonic and isometric mouth exercises geared toward the lips, tongue, soft palate and lateral pharyngeal wall — reduced apnea-hypopnea indices in older patients with obstructive sleep apnea, or OSA, according to research discussed at the SLEEP annual meeting.

A proof-of-concept system with smart devices such as an Amazon Echo and Apple iPhone was able to effectively identify agonal breathing associated with cardiac arrest, according to a study published in NPJ Digital Medicine.

Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in June.

Among patients with obstructive sleep apnea and excessive daytime sleepiness, solriamfetol significantly increased wakefulness and reduced sleepiness with mostly mild or moderate adverse events, according to results from the TONES 3 study published in the American Journal of Respiratory and Critical Care Medicine.